Keppra (levetiracetam) - Important Safety Information from UCB as approved by the Irish Medicines Board
07 February 2011
Important Safety Information communication from USB (Pharma) Ireland Ltd: Potential for dosing error when using Keppra (levetiracetam) oral solution due to change in syringe graduation markings, and new presentations for infants and children younger than 4 years of age.
Important safety information - Keppra (levetiracetam)